Lv51
1090 积分 2023-03-13 加入
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
1个月前
已完结
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
CD-19 CAR-T cells for polyrefractory rheumatoid arthritis
1个月前
已完结
Epidemiology of Sjögren syndrome
1个月前
已完结
Idiopathic inflammatory myopathies: current insights and future frontiers
2个月前
已完结
Predictors of rituximab effect on modified Rodnan skin score in systemic sclerosis: a machine-learning analysis of the DesiReS trial
2个月前
已完结
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
2个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
2个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
2个月前
已完结
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
2个月前
已完结
皖公网安备34019202002308
